Search results for "Antiplatelet therapy"
Did you mean "antiplatelet agents"?
Sort by: Relevance | Newest | OldestStudy of DAPT after TIA or minor stroke finds high-risk subgroup benefits more, has higher bleeding rates
The absolute but not the relative efficacy of dual antiplatelet therapy (DAPT) over aspirin varied by stroke risk among patients who had already had a transient ischemic attack (TIA) or minor ischemic stroke.
https://immattersacp.org/weekly/archives/2024/01/09/2.htm
9 Jan 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Three months after PCI, discontinuing aspirin associated with less bleeding than continued dual antiplatelet therapy
High-risk patients who were randomized to switch to ticagrelor plus placebo had similar rates of cardiovascular events as those who continued ticagrelor plus aspirin, an industry-funded trial found.
https://immattersacp.org/weekly/archives/2019/10/08/2.htm
8 Oct 2019
Warnings on long-term dual antiplatelet therapy, more
This update covers the recall of rapid gram-negative combo panels, approval of an extended-release opioid analgesic, and a new rule about labeling prescription drugs related to pregnancy and lactation.
https://immattersacp.org/archives/2015/02/fda.htm
1 Feb 2015
Timing of stroke treatment, preventive therapies presented at stroke meeting
Results of multiple studies examining transfers of acute stroke patients for thrombectomy, delayed use of thrombolysis plus thrombectomy or tenecteplase, and anticoagulation for secondary prevention after cryptogenic stroke were reported at the International Stroke Conference.
https://immattersacp.org/weekly/archives/2024/02/13/2.htm
13 Feb 2024
New guidelines for dual antiplatelet therapy in patients with CAD
Clinicians should weigh ischemic risks and bleeding risks before adding a P2Y12 inhibitor to aspirin monotherapy or prolonging dual antiplatelet therapy, among other recommendations.
https://immattersacp.org/weekly/archives/2016/04/05/2.htm
5 Apr 2016
Take TIAs as seriously as a stroke
Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://immattersacp.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023
Trial of apixaban with single and combination antiplatelet therapy in ACS stopped early due to observed increase in major bleeding events
Full-dose anticoagulation, in combination with antiplatelet therapy of any kind in patients with acute coronary syndrome, results in substantial bleeding without any clear additional benefit and should only be considered when required for another condition.
https://immattersacp.org/weekly/archives/2015/08/11/4.htm
11 Aug 2015
Dual antiplatelet therapy may be safer than triple therapy in older patients with acute MI, afib after PCI
Older patients with acute myocardial infarction and atrial fibrillation who have undergone percutaneous coronary intervention appear to have a higher risk for major bleeding, both early and long-term, with triple therapy versus dual antiplatelet therapy.
https://immattersacp.org/weekly/archives/2015/08/04/4.htm
4 Aug 2015
Harms of antiplatelet therapy may outweigh benefits in chronic kidney disease
Antiplatelet therapy may have uncertain benefits that could be outweighed by bleeding risk in patients with chronic kidney disease, according to a new study.
https://immattersacp.org/weekly/archives/2012/03/20/6.htm
20 Mar 2012